This is an old revision of this page, as edited by 1.186.123.90(talk) at 10:17, 8 September 2018(Added content). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 10:17, 8 September 2018 by 1.186.123.90(talk)(Added content)
Currently, it is only legal in 7 countries: Japan, Germany, China, South Korea, Bangladesh, Pakistan, and Venezuela. It is available in India also.
References
^Horiguchi, T.; Kondo, R.; Miyazaki, J.; Fukumokto, K.; Torigoe, H. (2011). "Clinical Evaluation of a Transdermal Therapeutic System of the ß2-Agonist Tulobuterol in Patients with Mild or Moderate Persistent Bronchial Asthma". Arzneimittelforschung. 54 (5): 280–285. doi:10.1055/s-0031-1296971. PMID15212190.